Cognition Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cognition Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, to vote on director elections and auditor ratification.
NASDAQ
Cognition Therapeutics has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Cognition Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 18, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Cognition Therapeutics has scheduled its annual stockholder meeting for June 7, 2024, and is urging shareholders to vote on key proposals, including the election of directors and ratification of the company's accounting firm.
NASDAQ
Cognition Therapeutics is holding its 2024 Annual Meeting of Stockholders virtually on June 7, 2024, to vote on the election of two Class III directors and the ratification of Ernst & Young LLP as its independent auditor.